Phase I Randomised, Five-period Cross-over Study in Healthy Male and Female Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Three Test Products With Two Reference Products
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2016
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Cystic fibrosis
- Focus Pharmacokinetics
- 13 Jul 2016 Status changed from recruiting to completed.
- 06 Apr 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 06 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Apr 2016, according to ClinicalTrials.gov record.